Despite variations by age group and influenza virus type, the 2023-2024 influenza vaccine was protective against outpatient illness in pediatric and adult patients.

Among nearly 700,000 adults ages 65 and older, the receipt of nine different intervention letters focused on increasing ...

Recommendations on the strain composition of influenza virus vaccines for the 2025-2026 US season have been issued by FDA.

This season's influenza vaccine may have been a poor match to a strain of the flu virus that caused many infections this winter, early data released by the Centers for Disease Control and ...

The 2024-2025 COVID-19 and influenza vaccines provided protection against ED/UC, outpatient visits, and hospitalizations. In the 2024-2025 season, the COVID-19 vaccine provided additional protection ...